
Peter A Kouides MD
Clotting Disorder, Hemophilia & Bleeding Disorder, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias
Medical and research director, Mary M. Gooley Hemophilia center, Clinical Professor of Medicine University of Rochester School of Medicine
Join to view full profile
1425 Portland AveRochester, NY 14621
Phone+1 585-922-4020
Fax+1 585-563-1832
Dr. Kouides is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Peter Kouides is a hematologist in Rochester, NY and is affiliated with Rochester General Hospital. He received his medical degree from State University of New York Upstate Medical University and has been in practice 32 years.
He specializes in benign hematology and is experienced in thrombotic disorders, bleeding disorders, hematological aspects/disorders of pregnancy general hematology, and Myeloproliferative disorders and MDS.
He is clinical professor of Medicine University of Rochester School of Medicine and adjunct faculty at Roswell Park Memorial Cancer Institute. He was an appointed member of the multi international 2021 Van Willebrand disease guidelines. His is past president of the Hemostasis and Thrombosis Research Society and past president of the Thrombosis and Hemostasis Societies of North America (THSNA). He has also served on the World Federation of Haemophilia twinning committee and has led two successive partnerships with his Rochester hemophilia treatment center and Bishkek, Kyrgyzstan then Kathmandu Nepal, four years each.
Education & Training
University of Rochester Medical CenterFellowship, Hematology and Medical Oncology, 1989 - 1993
Tufts Medical CenterResidency, Internal Medicine, 1986 - 1989
SUNY Upstate Medical UniversityClass of 1986
Certifications & Licensure
NY State Medical License 1989 - 2028
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification SoftLab, SCC Soft Computer, 2013-2017
- CMS Meaningful Use Stage 1 Certification SoftLab, SCC Soft Computer, 2013-2017
Clinical Trials
Publications & Presentations
PubMed
- Mortality prediction in immune TTP remains challenging despite artificial intelligence advances.Mouhamed Yazan Abou-Ismail, Meera Sridharan, Sanjana Kashinath, Mukul Singal, Rishabh Singh
Blood Advances. 2026-10-27 - Influenza as a Less Commonly Recognized Cause of Hemophagocytic Lymphohistiocytosis: A Systematic Review of Case Reports and Case Series.Kavya Balusu, Ali Abdelhay, Fnu Payal, Peter Kouides
European Journal of Haematology. 2026-10-01 - An unusual case of severe acquired coagulopathy from cancer cachexia-related vitamin K deficiency.Kavya Balusu, Cher Ying Foo, Peter Kouides
Blood Coagulation & Fibrinolysis. 2026-10-01
Abstracts/Posters
- Association of Obesity on Laboratory Profiles of Individuals with Type 1 Von Willebrand Disease and Low VWF in the Athn DatasetPeter A. Kouides, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center StudyPeter A. Kouides, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Congenital FVIII/IX or VWF Deficiency Does Confer a Lower Rate of Myocardial Infarction-Related Mortality Despite Decreased Cardiovascular InterventionsPeter A. Kouides, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: